How is diosmin made? Exploring the industrial synthesis process

Diosmin, a flavonoid commonly used to treat venous diseases, is predominantly manufactured through a semi-synthetic process starting from another flavonoid found in citrus peels. This manufacturing route is necessary because the concentration of diosmin in citrus fruits is too low for cost-effective extraction, whereas the starting material, hesperidin, is abundant. The process transforms the hesperidin molecule into the desired diosmin via a series of chemical reactions.

Quick Summary

The production of diosmin is primarily a semi-synthetic process involving the chemical modification of hesperidin, a flavonoid found in citrus fruit peels. Hesperidin undergoes oxidation, often using iodine, followed by purification steps to yield the final diosmin product.

Key Points

• Semi-Synthetic Origin: Diosmin is primarily manufactured through a semi-synthetic process using hesperidin, a common citrus flavonoid, as the starting material.

• Hesperidin Extraction: The process begins by extracting hesperidin from citrus fruit peels, where it is found in high concentrations.

• Key Chemical Conversion: A crucial step involves the oxidation and dehydrogenation of hesperidin, often catalyzed by iodine or bromine, to create the double bond that distinguishes diosmin.

• Purification is Critical: Multiple purification steps, including solvent distillation and recrystallization, are essential to remove impurities and achieve pharmaceutical-grade purity.

• Micronization for Bioavailability: The final product is often micronized to reduce particle size, which significantly improves its absorption and effectiveness.

• Modern Innovations: Research is ongoing to develop more eco-friendly and cost-effective methods, including novel solvent-free processes and potential biosynthesis routes.

• Pharmaceutical Standards: Manufacturing must adhere to strict pharmacopoeia standards (e.g., European Pharmacopoeia) for purity and safety.

Understanding the Raw Materials

Before delving into how is diosmin made, it is crucial to understand the starting material. Diosmin is a flavonoid with a specific flavone glycoside structure. Its precursor is hesperidin, a related flavanone glycoside, which is found in much higher concentrations in the peels of citrus fruits like oranges and lemons. Hesperidin is extracted from the fruit peel, and then its molecular structure is modified to create diosmin. The primary chemical difference lies in a double bond present in the central carbon ring of diosmin that is absent in hesperidin, requiring an oxidation and dehydrogenation step.

The Industrial Semi-Synthetic Process

The semi-synthetic method for producing diosmin from hesperidin is a multi-step chemical conversion process designed for industrial scale production. While specific procedures vary depending on patents and manufacturing efficiency, the core chemical transformations remain consistent.

• Hesperidin Extraction: The process begins with the extraction of hesperidin from dried citrus fruit peels using solvent-based methods, often involving aqueous ethanol.
• Acylation (Optional): Some processes include an initial acylation step where the hydroxyl groups of hesperidin are protected. This can help control the reaction and improve yield. This is typically done using a carboxylic acid anhydride like acetic anhydride.
• Dehydrogenation/Oxidation: This is the most critical step, where hesperidin is converted to diosmin. The reaction involves the use of a halogen, such as iodine ($I_2$) or bromine ($Br_2$), along with a base like pyridine or a high-boiling solvent such as dimethylformamide. The process, conducted under controlled heat and pressure, removes hydrogen atoms and introduces the necessary double bond.
• Purification: After the main reaction, the mixture contains crude diosmin and various impurities, including residual reagents and by-products. The purification process typically involves several stages, including:
  • Concentration under reduced pressure to remove solvents like pyridine.
  • Washing and filtration using aqueous solutions to separate the solid product from liquid impurities.
  • Recrystallization from solvents like aqueous dimethylformamide to achieve high purity.
  • Acidification steps to precipitate the final product.
• Micronization: For use in pharmaceuticals, the diosmin powder is often micronized. This process reduces the particle size to improve intestinal absorption and bioavailability, a crucial final step for products like Micronized Purified Flavonoid Fraction (MPFF).

Comparison of Production Methods

Feature	Semi-synthetic Production from Hesperidin	Direct Extraction from Plants	Tailored Biosynthesis
Starting Material	Abundant hesperidin from citrus peels.	Various plants like Hyssopus officinalis or Scrophularia nodosa.	Flavonoid precursor genes expressed in E. coli or N. benthamiana.
Availability	Dependent on agricultural supply of citrus fruit peels.	Limited by natural abundance and growth factors.	Lab-based; potentially scalable but currently less established for commercial volume.
Cost-Effectiveness	Generally more cost-effective for commercial quantities due to hesperidin abundance.	Often higher cost due to low concentration in plant material.	Emerging technology; costs are still being optimized.
Environmental Impact	Traditional methods use organic solvents (e.g., pyridine), creating environmental challenges, though greener methods are being developed.	Can use organic solvents for extraction but potentially lower impact depending on solvent choice.	Aims to be more environmentally friendly by avoiding harsh chemical reagents.
Product Purity	High purity is achievable with robust purification and crystallization steps.	May require extensive purification to separate from other plant compounds.	High purity is a major goal, with development aiming for specific flavonoid production.

Modern Innovations in Diosmin Manufacturing

The traditional method of using iodine and pyridine has been improved to address cost and environmental concerns. Newer, more sustainable methods include using different solvents with lower toxicity and higher recovery rates. Patents have detailed alternative processes involving modified reagents and conditions to increase yield and purity while minimizing waste. For instance, some processes utilize an aqueous medium throughout, avoiding the use of volatile and toxic organic solvents entirely. In addition to chemical synthesis, there is also emerging research into biosynthetic production, where genes encoding the necessary enzymes are expressed in microorganisms or plants to produce diosmin directly. This approach could offer a cleaner, more stable, and potentially more efficient manufacturing route in the future.

Conclusion

In conclusion, the production of diosmin is a sophisticated industrial process built on the semi-synthesis of hesperidin, a flavonoid readily available from citrus fruits. From the initial extraction of hesperidin to its chemical transformation via oxidation and multiple stages of purification and micronization, each step is critical for yielding a high-quality product suitable for pharmaceutical applications. Ongoing research and development continue to focus on improving the process to be more cost-effective, environmentally friendly, and efficient, ensuring a consistent and high-quality supply for the health and wellness markets worldwide.

---

Further Reading: For an in-depth review of diosmin's potential therapeutic roles and pharmacology, consult this article: Potential and Therapeutic Roles of Diosmin in Human Diseases.

Frequently Asked Questions

What is the primary starting material for making diosmin?

The primary starting material is hesperidin, a flavonoid found in large quantities in the peels of citrus fruits like oranges and lemons.

Why is diosmin not simply extracted from plants directly?

While diosmin occurs naturally in some plants, its concentration is typically too low for cost-effective industrial extraction, making the semi-synthetic conversion from more abundant hesperidin the preferred method.

What is the key chemical reaction in diosmin production?

The key reaction is the oxidation and dehydrogenation of hesperidin. This chemical process adds a double bond to the central carbon ring, converting the hesperidin molecule into diosmin.

What is the purpose of micronization in the manufacturing process?

Micronization is a final processing step that reduces the particle size of the diosmin powder. This significantly increases its solubility and absorption in the body, which is vital for its therapeutic effectiveness.

Are there environmental concerns associated with traditional diosmin production?

Yes, traditional synthesis methods often involve toxic organic solvents like pyridine. However, new patents and research are focused on developing greener, more environmentally friendly processes that minimize or eliminate these harmful chemicals.

What are the quality standards for diosmin manufacturing?

High-quality diosmin production is governed by strict pharmaceutical standards, such as those set by the European and United States Pharmacopoeias, to ensure high purity and safety.

What is the future of diosmin production?

Future production may move toward more sustainable methods, including engineered biosynthesis in microorganisms or plants, to avoid the environmental issues associated with chemical synthesis and ensure a stable supply.